Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-24-057010 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
116.19% · OPTIONAL · VALID
Capex intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.22% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.27% · OPTIONAL · VALID
Revenue growth 35th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-1.36% · CORE · VALID
Inventory pressure 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
54.07% · OPTIONAL · VALID
Gross margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.14% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
15.31% · CORE · VALID
R&D intensity 40th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.47% · OPTIONAL · VALID
SBC intensity 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.69% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 136.95%
Current 116.19%
Delta -20.76% Capex Intensity Decreased
Previous 5.64%
Current 4.22%
Delta -1.42% Cash Generation Increased
Previous 10.96%
Current 17.27%
Delta 6.31% Growth Decreased
Previous -0.73%
Current -1.36%
Delta -0.63% Inventory Pressure Decreased
Previous 64.41%
Current 54.07%
Delta -10.33% Margin Increased
Previous 22.76%
Current 24.14%
Delta 1.39% Profitability Increased
Previous 14.20%
Current 15.31%
Delta 1.11% R And D Intensity Decreased
Previous 1.57%
Current 1.47%
Delta -0.09% Sbc Intensity Increased
Previous 0.63%
Current 0.69%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.